Suppr超能文献

过氧化物酶体增殖物激活受体 γ 激动剂 - 罗格列酮和 15-脱氧-Δ-前列腺素 J 在实验性环孢素 A 肝毒性中的作用。

The role of PPAR gamma agonists - rosiglitazone and 15-deoxy-Δ-prostaglandin J in experimental cyclosporine A hepatotoxicity.

机构信息

Department of Pediatric, Regional Hospital, Lublin, Poland.

Department of Mathematics and Biostatistics, Medical University, Poland.

出版信息

J Physiol Pharmacol. 2019 Dec;70(6). doi: 10.26402/jpp.2019.6.07. Epub 2020 Feb 19.

Abstract

Cyclosporine A (CsA) is an immunosuppressive drug used in transplantation and treatment of autoimmune diseases. Experimental studies revealed impairments in liver function and morphology among cyclosporine-treated animals. The aim of the study was to evaluate hepatoprotective activity of peroxisome-proliferator-activated receptors γ (PPARγ) ligands: rosiglitazone and 15-deoxy-Δ-prostaglandin J (PGDJ2) on CsA-induced hepatotoxicity in experimental animals. CsA was administered subcutaneously at a dose of 15 mg/kg/day for 28 days. Both PPARγ agonists were given for 28 days 0.5 hour before the administration of CsA. Rosiglitazone was administered orally at a dose of 8 mg/kg/day and PGDJ2 was given intraperitoneally at a dose of 30 μg/kg/day. CsA induced liver injury was evidenced by increased serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and bilirubin. Concentrations of glutathione (GSH) and glutathione disulfide (GSSG), lipid peroxidation products, nicotinamide adenine dinucleotide+/nicotinamide adenine dinucleotide hydrogen (NAD/NADH), nicotinamide adenine dinucleotide phosphate+/nicotinamide adenine dinucleotide phosphate hydrogen (NADP/NADPH) and adenosine diphosphate/adenosine triphosphate (ADP/ATP) ratios and caspase 3 activity that were measured in the liver tissue showed, that CsA induced oxidative stress, evoked an imbalanced redox state and apoptosis in the liver. Microscope examination showed sinusoidal dilatation, mononuclear cell infiltration, necrosis of hepatocytes, intracellular vacuolar degeneration and microvesicular steatosis and apoptopic cells. The biochemical and morphological changes induced by CsA were limited by administration of both PPARγ agonist - rosiglitazone and PGDJ2. Our biochemical and liver histopathological examination indicate that both PPARγ agonists may play an important role in protecting against CsA-induced hepatotoxicity.

摘要

环孢素 A(CsA)是一种用于移植和治疗自身免疫性疾病的免疫抑制剂。实验研究表明,在接受环孢素治疗的动物中,肝功能和形态学受损。本研究旨在评估过氧化物酶体增殖物激活受体 γ(PPARγ)配体:罗格列酮和 15-脱氧-Δ-前列腺素 J(PGDJ2)对实验动物中 CsA 诱导的肝毒性的肝保护活性。CsA 以 15mg/kg/天的剂量皮下给药,共 28 天。两种 PPARγ 激动剂均在 CsA 给药前 0.5 小时给予 28 天。罗格列酮口服给药剂量为 8mg/kg/天,PGDJ2 腹腔内给药剂量为 30μg/kg/天。CsA 诱导的肝损伤表现为血清天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)和胆红素水平升高。肝组织中测定的谷胱甘肽(GSH)和谷胱甘肽二硫化物(GSSG)、脂质过氧化产物、烟酰胺腺嘌呤二核苷酸+/烟酰胺腺嘌呤二核苷酸氢(NAD/NADH)、烟酰胺腺嘌呤二核苷酸磷酸+/烟酰胺腺嘌呤二核苷酸磷酸氢(NADP/NADPH)和腺苷二磷酸/三磷酸腺苷(ADP/ATP)比值以及 caspase 3 活性表明,CsA 诱导了氧化应激,导致肝脏的氧化还原状态失衡和细胞凋亡。显微镜检查显示窦扩张、单核细胞浸润、肝细胞坏死、细胞内空泡变性、微泡性脂肪变性和凋亡细胞。CsA 诱导的生化和形态学变化受到两种 PPARγ 激动剂 - 罗格列酮和 PGDJ2 的限制。我们的生化和肝组织病理学检查表明,两种 PPARγ 激动剂可能在预防 CsA 诱导的肝毒性方面发挥重要作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验